None
Quote | Iterum Therapeutics plc (NASDAQ:ITRM)
Last: | $1.43 |
---|---|
Change Percent: | 0.7% |
Open: | $1.42 |
Close: | $1.43 |
High: | $1.51 |
Low: | $1.42 |
Volume: | 59,817 |
Last Trade Date Time: | 04/19/2024 03:00:00 am |
News | Iterum Therapeutics plc (NASDAQ:ITRM)
2024-04-08 08:23:12 ET More on pre-market losers & stocks. Perion Network: The Price Is Too Low To Ignore, Potentially Worth At Least Double Perion Network: Profitable Growth Company Trading At A Discount Iterum Therapeutics plc (ITRM) Q4 2023 Earnings Call Trans...
2024-03-28 11:53:39 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Iterum Therapeutics (NASDAQ: ITRM ) just reported results for the fourth quarter of 2023. Iterum Therapeutics reported earnings per share of -81 cents. This was above the ...
Message Board Posts | Iterum Therapeutics plc (NASDAQ:ITRM)
Subject | By | Source | When |
---|---|---|---|
Interesting his $ITRM release info about its drugs | pillskill | investorshub | 04/25/2023 5:37:30 PM |
Every day we're a little closer to FDA approval. | velcro | investorshub | 04/14/2023 11:42:00 PM |
$ITRM some Insider Buying showing up ! | swanlinbar | investorshub | 04/13/2023 4:20:21 PM |
$ITRM >Iterum Therapeutics Reports Fourth Quarter and Full | swanlinbar | investorshub | 03/21/2023 3:47:53 PM |
All niotech went up. And same reset. Its | Harbor6460 | investorshub | 03/01/2023 12:36:30 AM |
News, Short Squeeze, Breakout and More Instantly...
Iterum Therapeutics plc Company Name:
ITRM Stock Symbol:
NASDAQ Market:
Swire Pacific Ltd. ADR (Class A) (SWRAY) is expected to report for Q4 2023 Troika Media Group Inc. (TRKAQ) is expected to report for quarter end 2023-12-31 American Environmental Partners Inc. (AEPT) is expected to report for quarter end 2023-12-31 Veolia Environnement S.A. ADR (VEOEY...
- -Resubmission of NDA On Track for Early Q2 24— - -Cash Runway into 2025, including through Potential FDA Approval in Early Q4 24-- --Company to host conference call today at 8:30amET-- DUBLIN, Ireland and CHICAGO, March 28, 2024 (GLOBE NEWSWIRE) -- Iterum ...